Zydus Cadila Ltd., of Ahmedabad, India, and Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, are partnering to tackle chikungunya, an emerging infectious disease in Africa, Asia and the Indian subcontinent. Terms are not disclosed, but the partnership agreement covers early stage development through the final commercialization of the vaccine.